NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase

被引：0
|
作者：
Zhimin Gu
Jiliang Xia
Hongwei Xu
Ivana Frech
Guido Tricot
Fenghuang Zhan
机构：
[1] University of Iowa,Department of Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation and Holden Comprehensive Cancer Center
[2] Southern Medical University,Institute of Cancer Research, School of Basic Medical Sciences
来源：
Journal of Hematology & Oncology | / 10卷
关键词：
NEK2; Pyruvate kinase; Multiple myeloma; Alternative splicing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase
    Gu, Zhimin
    Xia, Jiliang
    Xu, Hongwei
    Frech, Ivana
    Tricot, Guido
    Zhan, Fenghuang
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 11
  • [2] Overexpression of Nek2 promotes bortezomib resistance in multiple myeloma cells.
    Flory, Jessica
    Brog, Rachel
    Meng, Ling Yao
    Call, Lee
    Vankayalapati, Hariprasad
    Tricot, Guido
    Zhan, Fenghuang
    Bearss, David J.
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [3] Targeting NEK2 kinase in drug resistant multiple myeloma with small molecule inhibitors
    Stephens, B.
    Xiao, F.
    Zangari, M.
    Xu, H.
    Tricot, G.
    Zhan, F.
    Mollard, A.
    Vankayalapati, H.
    Sharma, S.
    Bearss, D.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 109 - 109
  • [4] NEK2 promotes drug resistance through enhancing autophagy by upregulation of beclin1 in multiple myeloma cells
    Xia, J.
    Chen, S.
    Zhang, J.
    Wu, X.
    Feng, X.
    Guo, J.
    Kuang, C.
    Zhu, Y.
    Meng, B.
    Liu, Z.
    Jian, X.
    Guan, Y.
    Wu, M.
    Xiang, J.
    Qiu, L.
    Zhou, J.
    Zhan, F.
    Zhou, W.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 341 - 341
  • [5] NEK2 Promotes Bortezomib Resistance through Enhancing Autophagy By Upregulation of Beclin1 in Multiple Myeloma Cells
    Xia, Jiliang
    He, Yanjuan
    Meng, Bin
    Zhang, Jingyu
    Wu, Xuan
    Feng, Xiangling
    Kuang, Chunmei
    Guo, Jiaojiao
    Lei, Qian
    Guan, Yongjun
    Shen, Yi
    Qiu, Lugui
    Zhou, Wen
    [J]. BLOOD, 2019, 134
  • [6] Targeting NEK2 Kinase In Drug-Resistant Multiple Myeloma with Small Molecule Inhibitors
    Zhan, Fenghuang
    Xiao, Fang
    Zangari, Maurizio
    Xu, Hongwei
    Mughal, Benjamin
    Tricot, Guido J.
    [J]. BLOOD, 2010, 116 (21) : 345 - 345
  • [7] The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival
    Naro, Chiara
    Barbagallo, Federica
    Chieffi, Paolo
    Bourgeois, Cyril F.
    Paronetto, Maria Paola
    Sette, Claudio
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (05) : 3218 - 3227
  • [8] Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment
    Lischer, Christopher
    Bruns, Heiko
    [J]. CELL REPORTS MEDICINE, 2023, 4 (10)
  • [9] Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
    Franqui-Machin, Reinaldo
    Hao, Mu
    Bai, Hua
    Gu, Zhimin
    Zhan, Xin
    Habelhah, Hasem
    Jethava, Yogesh
    Qiu, Lugui
    Frech, Ivana
    Tricot, Guido
    Zhan, Fenghuang
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2877 - 2893
  • [10] NEK2 Suppresses Cellular Senescence through Regulation of the β-Catenin/CCND2/RB Axis in Multiple Myeloma
    Yang, Ye
    Tricot, Guido J.
    Xia Jiliang
    Gu, Zhimin
    Xu, Hongwei
    Hao, Mu
    Zhan, Fenghuang
    [J]. BLOOD, 2014, 124 (21)
12345